To further characterize the presence of COL4A1 and ITGAV in ccRCC, we examined the Clinical Proteomic Tumor Analysis Consortium (CPTAC), The Cancer Genome Atlas (TCGA), and the Genotype-Tissue Expression (GTEx) project [21, 22]. This evidence concerns the gene COL4A1 and nonpapillary renal cell carcinoma.